Publikation

Cutaneous malignant lymphomas: update 2006

Wissenschaftlicher Artikel/Review - 01.11.2006

Bereiche
PubMed
DOI

Zitation
Burg G, Nestle F, Schärer L, Michaelis S, Golling P, Feit J, Döbbeling U, Cozzio A, Kempf W, Dummer R. Cutaneous malignant lymphomas: update 2006. J Dtsch Dermatol Ges 2006; 4:914-33.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Dtsch Dermatol Ges 2006; 4
Veröffentlichungsdatum
01.11.2006
eISSN (Online)
1610-0387
Seiten
914-33
Kurzbeschreibung/Zielsetzung

Cutaneous lymphomas represent a unique group of lymphomas and are the second most frequent extranodal lymphomas. As with other neoplasias, the pathogenesis is based mainly on a stepwise accumulation of mutations of suppressor genes and oncogenes caused by genetic, environmental or infectious factors. The diagnostic work-up includes clinical, histological, imaging and hematological investigations and in many cases immunohistochemical and molecular biological analyses. The current WHO/EORTC classification of cutaneous lymphomas differentiates "mature T-cell and NK-cell lymphomas", "mature B-cell lymphomas" and "immature hematopoietic malignancies", their variants and subgroups. It is compatible with the WHO classification for neoplasias of the hematopoietic and lymphoid tissue and respects the organ-specific peculiarities of primary cutaneous lymphomas. The assignment of the various types of cutaneous lymphomas into prognostic categories (pre-lymphomatous "abortive" disorders; definite malignant lymphomas of low-grade malignancy; definite malignant lymphomas of high-grade malignancy) provides essential information on the biological behavior and allows an appropriate planning of the therapeutic strategy, which may be topical or systemic and aggressive or non-aggressive. Besides the classical options for therapy, there are new and "experimental" strategies, the efficacy of which has to be studied in clinical trials.